CD14‐independent responses induced by a synthetic lipid A mimetic
Open Access
- 3 March 2010
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 40 (3) , 797-802
Abstract
CRX‐527 belongs to a new family of synthetic lipid A mimetics, the aminoalkyl glucosaminide 4‐phosphates, which are considered as potential vaccine adjuvants or stand‐alone immunotherapeutics to harness innate immune defenses. Since natural lipid A from bacterial LPS depends on membrane‐bound (mCD14) or soluble CD14 for its TLR4 ligand activity, we investigated the involvement of both forms of CD14 in the responses elicited by CRX‐527. First, we found that CRX‐527 induces NF‐κB and interferon regulatory factor‐3 (IRF‐3) activation in human embryonic kidney cells transfected with TLR4 and MD‐2 genes alone, whereas the responses to LPS require either co‐transfection of the gene encoding mCD14 or addition of soluble CD14. We then observed that monocyte‐derived DC, which are devoid of mCD14 respond to CRX‐527 but not to LPS in serum‐free medium. Furthermore, we found that, in contrast to LPS, CRX‐527 induces the production of cytokines in whole blood of a patient with paroxysmal nocturnal hemoglobinuria, a disease in which mCD14‐dependent responses are defective. Finally, we demonstrated that splenocytes from CD14‐deficient mice produce cytokines in response to CRX‐527 but not to LPS. We conclude that the lipid A mimetic CRX‐527 does not require the CD14 co‐receptor to elicit TLR4‐mediated responses.Keywords
This publication has 15 references indexed in Scilit:
- New horizons in adjuvants for vaccine developmentTrends in Immunology, 2009
- TLR4 agonists as immunomodulatory agentsInnate Immunity, 2006
- Lipopolysaccharide signaling in endothelial cellsLaboratory Investigation, 2006
- CD14 is required for MyD88-independent LPS signalingNature Immunology, 2005
- Endotoxin recognition and signal transduction by the TLR4/MD2-complexMicrobes and Infection, 2004
- Innate recognition of lipopolysaccharide by Toll-like receptor 4–MD-2Trends in Microbiology, 2004
- Structure-Activity Relationship of Synthetic Toll-like Receptor 4 AgonistsJournal of Biological Chemistry, 2004
- Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling PathwayScience, 2003
- Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529Innate Immunity, 2002
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994